Lower serum levels of bile acids in the HFHF group may reduce the activation of FXR and enhance the fat accumulation in the rat liver which is similar to NAFLD pathologies. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.